Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase NA 2Phase EARLY_PHASE1 2Phase 3 1

Status

Completed 2Terminated 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

NET 1Endocrine 1

Conditions

Neuroendocrine Tumors 1Carcinoma, Medullary 1

Interventions

Exercise 216Blood Specimen Collection 122Surveys and Questionnaires 117Standard of Care 114Magnetic Resonance Spectroscopy 113Early Intervention, Educational 108Educational Status 102Methods 101Radiotherapy 94Radiosurgery 76Counseling 72Control Groups 64Biopsy 61Acupuncture Therapy 60Therapeutics 57Psychiatric Rehabilitation 55Resistance Training 53Saline Solution 49Cyclophosphamide 48Palliative Care 46Yoga 41Practice Guidelines as Topic 41Cognitive Behavioral Therapy 41Metformin 40Interviews as Topic 40Drug Therapy 37Surgical Procedures, Operative 36Radiofrequency Ablation 35Dexmedetomidine 35Patient Navigation 34

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Completed × fluorodopa F 18 × Clear all
NCT02856347 2025-11-18

CMTpostopFDOPA

Institut Claudius Regaud

Phase NA Completed
24 enrolled

Carcinoma, Medullary

NCT02539433 2015-09-03

Imaging of Neuroendocrine Tumors With PET and Fluoro-18-DOPA (F-DOPA)

Northwell Health

Phase NA Completed
22 enrolled
EndocrineNET

Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡